CLINICAL_TRIALS
ClinicalTrials.gov record update
Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90®) in Patients With Parkinson's Disease: Changes in Biomarkers of Oxidative Stress, Profiles of Plasma Amino Acids and Their Derivatives and Brain Function
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01662414
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:35:37.264648+00:00
- Published At
- 2013-09-30T00:00:00+00:00
- Record Updated At
- 2013-09-30
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Parkinson Disease", "Parkinsonian Disorders", "Basal Ganglia Diseases", "Brain Diseases", "Central Nervous System Diseases", "Nervous System Diseases", "Movement Disorders", "Neurodegenerative Diseases"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2013-09-30"- protocolSection.identificationModule.nctId
"NCT01662414"- protocolSection.identificationModule.officialTitle
"Effect of Undenatured Cysteine-Rich Whey Protein Isolate (HMS 90\u00ae) in Patients With Parkinson\u0027s Disease: Changes in Biomarkers of Oxidative Stress, Profiles of Plasma Amino Acids and Their Derivatives and Brain Function"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.